Tilray Exports Medical Cannabis Genetics To The European Union

Europe is going green

PORTUGAL: Tilray, a GMP-certified global leader in medical cannabis research and production, today announced that the company has successfully exported live medical cannabis genetics from its flagship British Columbia, Canada facility to its European Union Campus in Cantanhede, Portugal. The announcement is the first time a company has legally exported live cannabis genetics from North America Read the full article…

Tilray Exports Medical Cannabis Products To New Zealand or Nationwide Distribution

Products currently available in New Zealand include precisely formulated medical cannabis oils containing tetrahydrocannabinol (THC) and cannabidiol (CBD).

CANADA: Tilray, a global leader in medical cannabis research and production, today announced that Tilray medical cannabis products have been successfully exported to New Zealand and are now available for distribution nationwide. The products were produced at Tilray’s federally licensed, Good Manufacturing Practice (GMP)-certified facility in Canada and can be dispensed to any patient with valid Read the full article…

Tilray Receives License to Produce Medical Cannabis In The European Union

Tilray to build European Union Campus in Portugal

Company Announces €20 Million Investment to Build EU Campus and Begin Operations this Year PORTUGAL: Tilray has announced plans today to invest up to €20 million in a European Union Campus after receiving licenses from the Government of Portugal to import cannabis genetics and to cultivate cannabis for medical purposes. “Tilray’s EU Campus is another strategic Read the full article…

Tilray Announces Second Facility To Meet Rapidly Growing Global Demand For Medical Cannabis

Total output to increase to 51 metric tonnes annually by end of 2018

CANADA: Tilray Canada Ltd., a global leader in medical cannabis research and production, has announced that it will invest, through an affiliated entity, up to $30 million in a second cultivation and processing facility located in Enniskillen, Ontario. The two facilities will generate a combined production capacity of up to 51 metric tonnes per year, which will Read the full article…

Tilray Announces Support For Clinical Trial Examining Cannabis And Chronic Lung Disease

Tilray clinical trials progress

CANADA: Tilray, a global leader in medical cannabis research and production, today announced a partnership with the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, one of the world’s premier public academic and research institutions, to study the effects of vaporized cannabis on symptoms associated with chronic obstructive pulmonary disease (COPD). The Phase II trial will Read the full article…

Tilray Announces Medical Cannabis Export To Cyprus

Tilray to export mmj to Cyprus

CANADA:  Tilray, a global leader in medical cannabis research and production, today announced that Tilray cannabinoid products have arrived and are cleared for distribution in European Union member state Cyprus after the company received necessary approvals in Canada and Cyprus to export cannabinoid formulations for patients in Cyprus. “We are proud to be able to offer Read the full article…

Tilray Completes First Bulk Medical Cannabis Export To Australia Under New Regulations

Tilray mmj products are going Down Under

CANADA: Tilray, a global leader in medical cannabis research and production, today announced it has completed its first import of medical cannabis products into Australia under the country’s new import regulations. The products were produced at Tilray’s federally licensed, GMP-certified facility in Canada and can be dispensed to any patient with a valid prescription. “We are Read the full article…

Tilray Becomes North America’s First GMP Certified Medical Cannabis Producer

Tilray

CANADA: Tilray, a global leader in medical cannabis research and production, today announced that it has become the first medical cannabis producer in North America to be GMP certified in accordance with the European Medicines Agency’s (EMA) Good Manufacturing Practice (GMP) standards. As North America’s only GMP certified medical cannabis producer, Tilray is uniquely positioned to expand Read the full article…

Doctors Being Paid For Medical Marijuana Referrals, Company Says

A major producer of medical marijuana says doctors and specialized clinics are receiving kickbacks from some licensed pot producers in exchange for sending them patients.

CANADA:  A major producer of medical marijuana says doctors and specialized clinics are receiving kickbacks from some licensed pot producers in exchange for sending them patients, a practice the company calls unethical and a violation of professional medical standards. Greg Engel, CEO of Nanaimo, B.C.-based Tilray, said his company recently resigned from the Canadian Medical Read the full article…

Seattle Marijuana Investment Firm Privateer Closes $75M Round To Build Global Cannabis Brands

Privateer Holdings is well on its way to becoming one of the country’s top marijuana investment firms.

WASHINGTON:  Privateer Holdings is well on its way to becoming one of the country’s top marijuana investment firms. The Seattle-based holding company today announced the closure of a $75 million Series B round, money that Privateer will use to grow its three marijuana-related startups and expand the firm’s portfolio further. “This positions us to build a family of global brands Read the full article…